Mourning the loss of Michael Frumovitz
Michael Frumovitz was a gynecologic oncologist at The MD Anderson Cancer Center. Dr. Frumovitz was an internationally renowned expert who the founded MD Anderson’s Rare Tumor Program. Dr. Frumovitz was the director of the MD Anderson Gynecologic Oncology Fellowship. He was a member of the American College of Obstetricians and Gynecologists and the Society of Gynecologic Oncologists where he was on the Government Relations Committee. He passed away on July 25th, 2024.
Friends and colleagues expressed their condolences on the passing of Michael Frumovitz.
Mark Lewis, Director of Gastrointestinal Oncology at Intermountain Healthcare in Utah, posted on X:
”RIP Michael Frumovitz.
You and I memorably discussed how institutions may not love you back but good colleagues can sustain you. Your legacy extends far beyond MD Anderson Cancer Center to elevate our entire profession with your compassion and patient-centrism.”
Source: Mark Lewis/X
Peter Pisters, President of The University of Texas MD Anderson Cancer Center, posted on X:
”Our MD Anderson Cancer Center team mourns the passing of Chief Patient Experience Officer Michael Frumovitz. He was an exceptional physician who dedicated his professional career to extending and bettering the lives of our patients. He was also an extraordinary colleague, friend and mentor to so many. Michael’s strength, his compassion, his wit and his impact will be felt for years to come. I will always be grateful for his commitment and the example he set for us all.”
Source: Peter Pisters/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023